Skip to main content

stock

IBIO · iBio, Inc.

What iBio, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live IBIO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on IBIO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
64,307,256 as of 2026-08-27 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-38.3%
ROA
-33.1%

Health

Current ratio
7.9x
Debt/equity
—

Deep value

NCAV
$78.82M
NCAV per share
$1.23
Price/NCAV
Locked
NNWC
$43.00M
NNWC per share
$0.67
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$11.38M-$10.40M
DEF 14A filed 2026-09-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2026-03-31——-$8.37M-$7.73M
10-Q filed 2026-05-12
2025-12-31$0—-$9.45M-$8.99M
10-Q filed 2026-05-12
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$100,000—-$5.95M-$5.72M
10-Q filed 2026-05-12
Assembled from more than one filing; the filing above is only the newest of them.
2025-06-30$200,000—-$5.20M-$5.17M
DEF 14A filed 2026-09-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$0—-$4.88M-$4.86M
10-Q filed 2026-05-12
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$200,000—-$4.42M-$4.36M
10-Q filed 2026-05-12
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—-$4.11M-$3.99M
10-Q filed 2026-05-12
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$99.11M
Equity
$85.71M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2026-06-30$100,000-$35.14M-$32.84M-$23.80M
2025-06-30$400,000-$18.60M-$18.38M-$15.32M
2024-06-30$225,000-$16.63M-$24.91M-$18.76M
2023-06-30$0-$29.34M-$65.01M-$36.17M
2022-06-30$1.88M-$29.70M-$50.30M-$44.81M
2021-06-30$2.37M-$31.11M-$23.21M-$34.98M
2020-06-30$0-$14.00M-$16.44M-$14.42M
2019-06-30$37,000-$15.79M-$17.59M-$14.89M
2018-06-30$44,000-$14.23M-$16.11M-$14.41M
2017-06-30$394,000-$14.27M-$14.53M-$14.49M

Company filings

since Fri Feb 27 · 3 offering filings in 12 months · since Fri Mar 6

events

  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Sep 148-K
  • Results

    Results
    Aug 288-K
  • Executive or director change, Other event

    Executive or director changeOther event
    Aug 48-K
  • Item 5.08, Other event

    Item 5.08Other event
    Jul 178-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Jul 18-K
  • Results

    Results
    May 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named IBIO, and the market events around them.

Sign in to see this

Board

The IBIO board could not be loaded.

Retry the IBIO board

nakagai

Signals on IBIO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the IBIO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

iBio, Inc. (IBIO): SEC filings, financials and insider trades · Nakagai